ArticleJournal of materials science. Materials in medicine2025
Evaluation of antibacterial and antibiofilm activities of green-synthesized iron oxide nanoparticles using Cyperus rotundus extract as a reducing and stabilizing agent.
Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Marine algae-derived Ag/AlJournal of materials science. Materials in medicine · 2026Article
- Advancing antifungal therapy: exploring targeted CFW-PEc-enhanced ethosomal formulations of amphotericin B against cryptococcal pneumonia.Microbiology spectrum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of Iron oxide nanoparticles (IONPs) from the green sources has significant attraction due to their eco-compatibility, safety, and nontoxic nature. This work demonstrated the synthesis of IONPs using the aqueous root extract of Cyperus rotundus, a traditional antibacterial plant source (Cr-IONPs). The synthesized Cr-IONPs were characterized by various analytical instruments DLS, Zeta, XRD, SEM, VSM, etc. to evaluate its physicochemical and magnetic nature. The results confirmed the uniform shape of Cr-IONPs within a size range of 30-70 nm. Additionally, they exhibited excellent colloidal stability with a Zeta potential value of -30.50 ± 1.79 mV. The VSM analysis revealed a superparamagnetic nature with zero remanence value. The antibacterial study showed that Cr-IONPs exhibited strong antibacterial potential in a concentration-dependent manner. Both Pseudomonas aeruginosa (P. aeruginosa) and Staphyllococcus aureus (S. aureus) strains demonstrated that Cr-IONPs exhibit potent antibacterial activity in a concentration-dependent manner. Furthermore, the diameter of the zone of inhibition increased with higher concentrations of the Cr-IONPs. These results demonstrate that the Cr-IONPs synthesized via a greener approach using C. rotundus extract exhibit strong antibacterial activity and biocompatibility, making them a promising candidate as a future antibacterial agent against multi-drug-resistant bacteria. Additionally, their superparamagnetic nature also broadens their potential for biomedical applications, including targeted drug delivery and diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.